peptide elongation factor 2 has been researched along with buthionine sulfoximine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ayala, A; Galigniana, MD; Machado, A; Piwien-Pilipuk, G | 1 |
1 other study(ies) available for peptide elongation factor 2 and buthionine sulfoximine
| Article | Year |
|---|---|
Impairment of mineralocorticoid receptor (MR)-dependent biological response by oxidative stress and aging: correlation with post-translational modification of MR and decreased ADP-ribosylatable level of elongating factor 2 in kidney cells.
Topics: ADP-Ribosylation Factors; Aging; Animals; Antimetabolites; Buthionine Sulfoximine; Cytosol; Enzyme Inhibitors; Glutathione; HSP90 Heat-Shock Proteins; Kidney; Male; Mice; Mice, Inbred BALB C; Oxidation-Reduction; Oxidative Stress; Oxygen; Peptide Elongation Factor 2; Polyribosomes; Precipitin Tests; Protein Binding; Protein Biosynthesis; Protein Processing, Post-Translational; Receptors, Mineralocorticoid; Reticulocytes; Time Factors; Transcription, Genetic | 2002 |